New CAR-T therapy aims to control aggressive blood cancer
Disease control
Recruiting now
This study tests a new treatment called TC011, which uses a patient's own immune cells (CAR-T cells) to fight a type of blood cancer called large B-cell lymphoma. The trial is for adults whose cancer has come back or not responded to at least two prior treatments. The goal is to …
Phase: PHASE1, PHASE2 • Sponsor: TICAROS Co., Ltd. • Aim: Disease control
Last updated May 04, 2026 16:31 UTC